Allergan Aesthetics Receives Positive CHMP Opinion for TrenibotulinumtoxinE for Glabellar Lines
The botulinum neurotoxin type E candidate is designed for a faster onset and shorter duration of effect than currently available neurotoxin treatments.
Search fresh public links, source activity, and ready-to-use post angles for Trenibotulinumtoxine.
Fresh curated links around trenibotulinumtoxinE are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The botulinum neurotoxin type E candidate is designed for a faster onset and shorter duration of effect than currently available neurotoxin treatments.
The product is the first botulinum toxin type E approved for aesthetic use and is designed to deliver faster onset and shorter-lasting results than traditional neurotoxins.
Ipsen has shared phase 2 data on its long-acting neurotoxin, reporting an increase in the proportion of people with significant improvements in frown lines 24 weeks after treatment...
Botulinum toxin type A may improve the aesthetic outcome of new scars in patients prone to abnormal scarring.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.